SIGY
Price:
$2
Market Cap:
$3.21M
Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
SIGY
According to Sigyn Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.04. This represents a change of -47.08% compared to the average of -1.97 of the last 4 quarters.
The mean historical PE Ratio of Sigyn Therapeutics, Inc. over the last ten years is -1.44. The current -1.04 PE Ratio has changed 7.14% with respect to the historical average. Over the past ten years (40 quarters), SIGY's PE Ratio was at its highest in in the March 2019 quarter at 3.64. The PE Ratio was at its lowest in in the March 2021 quarter at -38.19.
Average
-1.44
Median
-0.25
Minimum
-6.65
Maximum
-0.03
Discovering the peaks and valleys of Sigyn Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.91%
Maximum Annual PE Ratio = -0.03
Minimum Annual Increase = -99.20%
Minimum Annual PE Ratio = -6.65
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.26 | 3.91% |
| 2023 | -0.03 | -26.78% |
| 2022 | -0.04 | -99.20% |
| 2021 | -5.35 | -19.61% |
| 2020 | -6.65 | 2.55% |
| 2019 | -0.25 | 4.56% |
| 2018 | -0.24 | 124.18% |
| 2017 | -0.11 | -65.72% |
| 2016 | -0.31 | 153.65% |
| 2015 | -0.12 | -82.34% |
The current PE Ratio of Sigyn Therapeutics, Inc. (SIGY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.44
5-year avg
-2.67
10-year avg
-1.44
Sigyn Therapeutics, Inc.’s PE Ratio is greater than Acrux Limited (-1.08), greater than ProtoKinetix, Incorporated (-6.69), greater than AXIM Biotechnologies, Inc. (-2.12), greater than Zelira Therapeutics Limited (-1.09), less than RepliCel Life Sciences Inc. (6.01), less than HAVN Life Sciences Inc. (-0.01), greater than Therma Bright Inc. (-60.81), greater than Pharmadrug Inc. (-4.80), less than Core One Labs Inc. (-0.28), greater than IR-Med Inc. (-1.47),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.08 | $4.11M | |
| -6.69 | $1.96M | |
| -2.12 | $7.33M | |
| -1.09 | $2.38M | |
| 6.01 | $7.36K | |
| -0.01 | $48.73K | |
| -60.81 | $2.03M | |
| -4.80 | $3.11M | |
| -0.28 | $22.14K | |
| -1.47 | $3.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sigyn Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sigyn Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sigyn Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Sigyn Therapeutics, Inc. (SIGY)?
What is the highest PE Ratio for Sigyn Therapeutics, Inc. (SIGY)?
What is the 3-year average PE Ratio for Sigyn Therapeutics, Inc. (SIGY)?
What is the 5-year average PE Ratio for Sigyn Therapeutics, Inc. (SIGY)?
How does the current PE Ratio for Sigyn Therapeutics, Inc. (SIGY) compare to its historical average?